Insights on Discovery

  1. Fast And Scalable Fc Quantitation In Supernatants 3/24/2025

    In biopharmaceutical development, the Fc PAIA Titer assay offers a fast, cost-effective, and automatable solution for high-throughput Fc quantification to enhance efficiency, support research, and accelerate production advancements.

  2. Evaluating Compound Toxicity Effects On Healthy Intestinal Organoids 3/24/2025

    3D organoids enhance drug toxicity prediction and are crucial for anti-cancer drug development. Examine a method using 3D mouse intestinal organoids that aims to provide vital data on intestinal toxicity.

  3. Cell Culture Automation Of The 3D Cancer Spheroid Assay 3/24/2025

    Discover how automated 3D cell culture methods enhance efficiency and consistency in high-throughput drug screening to accelerate the discovery of new anti-cancer therapies.

  4. mTOR Pathway 3/24/2025

    Explore the mTOR signaling pathway and reveal how mTORC1 regulates cell growth, metabolism, and survival to ensure cellular function and adaptation to environmental cues.

  5. VEGF Signaling Pathway 3/24/2025

    In Alzheimer's disease, reduced VEGF levels are linked to neurodegeneration, which can offer therapeutic potential. Discover how experimental treatments show promise in reducing memory impairment and beta-amyloid deposition.

  6. Neuroinflammation In Alzheimer's Disease Pathway 3/24/2025

    Recent research highlights neuroinflammation's role in AD progression, which suggests immune modulation as a potential therapeutic strategy. Learn more about neuroinflammatory processes in AD pathology.

  7. Alzheimer's Disease Pathway 3/24/2025

    Alzheimer’s disease (AD) affects 50 million people globally, causing cognitive decline. Explore the signaling pathways of amyloid beta and tau proteins, linking them to neuronal death and AD symptoms.

  8. Studying The Spatial Architecture Of Glioblastoma 3/24/2025

    Explore how intra-tumor heterogeneity (ITH) impacts cancer progression and therapy resistance with advanced imaging platforms and custom antibody panels to reveal the spatial architecture of glioblastoma (GBM).

  9. Multiplex Imaging 3/24/2025

    Explore recombinant antibody reagents that support the imaging of key targets within the TME and offer flexible solutions across various platforms to improve patient outcomes.

  10. Enhanced Validation Data Anti-EGFRvIII Recombinant Antibody 3/24/2025

    Select the right antibody clone by exploring enhanced validation data for top recombinant antibody clones that offer comprehensive specificity and sensitivity insights tailored to your project's unique requirements.